Exploring associations between psychiatric disorder, psychological distress, and health care utilization in cancer patients
ConclusionPsychiatric disorder and psychological distress were associated with mental health care use and costs. Psychological distress was associated with complementary health care use. Adequate assessment and referral to mental health care might prevent unnecessary health care utilization.
Conclusion These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
(Reuters Health) - - Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with the disease, a research review suggests.
ConclusionsChemotherapy-na ïve patients with metastatic castration-resistant prostate cancer experience a substantial burden from their condition. Furthermore, as castration-resistant prostate cancer progresses from the non-metastatic stage to the early metastatic (pre-chemotherapy) stage, certain symptoms become more common and disturb patients’ lives to a greater extent. The resulting conceptual model for metastatic castration-resistant prostate cancer highlights areas that are not adequately assessed with current patient-reported outcome instruments.
You're reading Hypnosis – what’s fact and what’s fiction?, originally posted on Pick the Brain | Motivation and Self Improvement. If you're enjoying this, please visit our site for more inspirational articles. Hypnosis is a technique that is both widely used and controversial. Many see it as a form of stage entertainment. True hypnosis, however, is very different and has valuable medical and therapeutic benefits, providing effective treatment to a variety of ailments - from anxiety and depression to chronic pain. To help you gain a deeper understanding of hypnosis, let’s look at how it works and unp...
Abstract IntroductionCancer-related drowsiness (CRD) is a distressing symptom in advanced cancer patients (ACP). The aim of this study was to determine the frequency and factors associated with severity of CRD. We also evaluated the screening performance of Edmonton Symptom Assessment Scale-drowsiness (ESAS-D) item against the Epworth Sedation Scale (ESS). METHOD: We prospectively assessed 180 consecutive ACP at a tertiary cancer hospital. Patients were surveyed using ESAS, ESS, Pittsburgh Sleep Quality Index, Insomnia Severity Index, and Hospital Anxiety Depression Scale.ResultNinety of 150 evaluable patients had...
Purpose: The purpose of this study was to determine, within the first year post-head and neck cancer (HNC) diagnosis, the contribution of past and current DSM psychiatric diagnoses (i.e., substance use disorder, major depressive disorder, and anxiety disorder) to extent of opioid prescriptions.
Publication date: Available online 28 November 2018Source: European Annals of Otorhinolaryngology, Head and Neck DiseasesAuthor(s): D. Chaillou, G. Mortuaire, V. Deken-Delannoy, B. Rysman, D. Chevalier, F. MouawadAbstractBackgroundIn oncology, multi-disciplinary team meetings improve overall survival and reduce time to treatment in head and neck cancer. Interestingly, no study has examined the experience of patients attending an MTM. The present study addressed two questions: Does the MTM cause anxiety/depression for patients who are present? Are patients satisfied at the end of the meeting?Patients and methodsThe study in...
Conditions: Depression, Anxiety; Information Disclosure Intervention: Sponsor: Rigshospitalet, Denmark Recruiting
Conclusion: Psychological problems are highest among patients from rural areas and among female patients compared to male. Highest anxiety and somatization was found among patients in Stage II cancer and depression in Stage IV cancer. Among treatment modalities, highest anxiety was found among patients under chemotherapy treatment, somatization among patients under both chemotherapy and radiotherapy, and depression among patients under radiotherapy treatment.
ConclusionsPatients with glioma grade II –III on levetiracetam had an increased risk for drug-treated anxiety. The subgroup of patients with glioma grade II–III and epilepsy received less antidepressants than the general population.